机械取栓治疗脑静脉窦血栓形成:病例系列与技术要点
该回顾性病例系列纳入2018-2019年7例对最佳药物治疗无反应的脑静脉窦血栓形成患者,采用大口径抽吸导管行抽吸取栓,其中4例术中辅助低剂量短时程窦内溶栓。所有患者术后24小时内临床改善,6例30天mRS为0,无操作相关并发症,提示该技术简单、安全、有效。
要点
- 对药物治疗无效的脑静脉窦血栓形成,抽吸取栓可考虑作为血管内治疗首选方式。
- 术中可辅助低剂量(10 mg rtPA)、短时程(20分钟)窦内溶栓,仅4例使用。
- 本组7例术后24小时内均临床改善,6例30天mRS为0,无操作相关并发症。
核心结论
- 所描述的抽吸取栓技术对药物治疗后恶化的脑静脉窦血栓形成患者简单、安全、有效,可实现窦完全或部分再通且操作时间较短。
研究设计与样本
- 回顾性评估本机构2018-2019年数据库,纳入7例接受大口径抽吸导管行抽吸取栓(伴或不伴术中窦内溶栓)的脑静脉窦血栓形成患者。
主要发现
- 7例患者均对最佳药物治疗无反应,抽吸取栓为主要血管内治疗方式。
- 仅4例术中辅助低剂量(10 mg重组组织型纤溶酶原激活剂)、短时程(20分钟)窦内溶栓。
- 头痛最常见,其次为癫痫发作、局灶性神经功能缺损和呕吐。
- 所有患者术后24小时内临床状况改善,6例30天改良Rankin量表评分为0。
- 1例遗留偏瘫和失语,无操作相关并发症。
临床怎么用
- 对最佳药物治疗后恶化的脑静脉窦血栓形成患者,可考虑采用大口径抽吸导管行抽吸取栓。
- 术中可选择性辅助低剂量(10 mg rtPA)、短时程(20分钟)窦内溶栓。
- 血管内取栓联合常规药物治疗可恢复脑最终引流途径并获得良好临床结局。
局限性
- 回顾性设计,样本量仅7例,证据等级有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cerebral venous sinus thrombosis is a rare cause of acute stroke. It may lead to hemorrhagic venous infarctions, brain swelling, or raised intracranial pressure and can be associated with significant mortality and morbidity. Low-molecular-weight heparin is the mainstay of treatment. Endovascular treatment is reserved for patients who deteriorate despite medical management. METHODS: Retrospective evaluation of our institutional databases from 2018-2019 revealed 7 patients who underwent aspiration thrombectomy using large-bore aspiration catheters for recanalization of the dural sinuses with or without intrasinus thrombolysis during the procedure. Their clinical, imaging findings, endovascular technique, and outcome are discussed. RESULTS: We treated 7 patients who did not respond to best medical management. Aspiration thrombectomy was the primary mode of endovascular treatment. Adjuvant low-dose (10 mg recombinant tissue plasminogen activator), short-duration (20-minute) intrasinus thrombolysis was used in 4 patients only during the procedure. Headache was the most common symptom, followed by seizures, focal neurologic deficits, and vomiting. There was improvement in clinical condition within 24 hours of procedure in all patients. The 30-day modified Rankin Scale score was 0 in 6 patients. One patient had residual hemiparesis and aphasia. There were no procedure-related complications. CONCLUSIONS: The described technique appears to be simple, safe, and effective and results in a relatively short procedure time in achieving complete or partial recanalization of the dural sinuses in patients who deteriorate despite clinical management. Endovascular thrombectomy along with conventional medical management restores the final drainage pathway of the brain with good clinical outcome.
引用
- Medhi G, Parida S, Nicholson P, et al. Mechanical Thrombectomy for Cerebral Venous Sinus Thrombosis: A Case Series and Technical Note. World Neurosurg. 2020. PMID: 32389866. doi:10.1016/j.wneu.2020.04.220
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。